To verify the possible mechanism of suppressing the progression of myopia by GBEs administration, we used real-time PCR to detect the expressions of Egr-1 and eNOS in the retina and the choroid after three weeks of GBEs oral administration. This evidence concerns the gene NOS3 and myopia.